GLP-1 receptor agonists, such as Ozempic, have revolutionized weight loss by helping individuals manage appetite and blood sugar levels
Click to view the research paper
We recommend completing at least 12 weeks for meaningful results, but there is no obligation to continue
This means patients with mild to moderate kidney disease (GFR 3060 mL/min/1.73m) can typically use standard semaglutide protocols without adjustment
69 Pegozafermin, a long-acting glycopegylated FGF21 analog, demonstrated improvement in liver fibrosis in MASH as shown in a 24-week phase 2B clinical trial (NCT04929483)
We selected the anterior cingulate cortex (ACC), thalamus, and right temporoparietal junction (rTPJ) for the MRS experiment, considering the roles of these regions in social function and sensory processing [31,32,33]